Home

Articles from ELIQUENT Life Sciences

ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, Rob will oversee the company’s strategic initiatives across its regulatory, quality, and compliance practice areas, further positioning ELIQUENT to meet the growing global demand for integrated regulatory, quality, and safety solutions across diverse markets.
By ELIQUENT Life Sciences · Via Business Wire · February 3, 2025
ELIQUENT Life Sciences Announces: Wendy Sanhai, Ph.D., MBA, Joins ELIQUENT Board of Directors
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Wendy Sanhai, Ph.D., MBA, to its Board of Directors. A trusted advisor to Fortune 500 pharmaceutical, biotechnology, and medical device companies, Dr. Sanhai’s appointment further positions ELIQUENT to meet the growing global demand for integrated regulatory, quality, and safety solutions across diverse markets.
By ELIQUENT Life Sciences · Via Business Wire · January 13, 2025
Shelley Gandhi Joins Firm – Headlines ELIQUENT’s Expanded Pharmacovigilance Service Offerings
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced that internationally recognized pharmacovigilance (PV) expert Shelley Gandhi has joined the firm. This strategic addition to ELIQUENT’s robust team of regulatory and quality leaders reinforces the firm’s commitment to delivering integrated solutions that streamline compliance, manage risk, and accelerate time-to-market.
By ELIQUENT Life Sciences · Via Business Wire · November 4, 2024
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-Pacific region. This strategic addition to ELIQUENT’s executive team underscores the company’s commitment to continued growth within European and Asian markets.
By ELIQUENT Life Sciences · Via Business Wire · October 31, 2024
ELIQUENT Life Sciences Announces Expanded Platform of Due Diligence Solutions
ELIQUENT Life Sciences, a global regulatory consulting firm, today announced an expanded portfolio of due diligence services tailored to the unique needs of the life sciences industry.
By ELIQUENT Life Sciences · Via Business Wire · April 22, 2024
ELIQUENT Life Sciences Announces Appointment of Former FDA Senior Officials
ELIQUENT Life Sciences, a global regulatory consulting firm for the life sciences industry, today announced the appointment of John Taylor as head of the firm’s Quality & Compliance Practice and Michele Dougherty as head of the firm’s Regulatory Affairs Practice.
By ELIQUENT Life Sciences · Via Business Wire · March 21, 2024
ELIQUENT Life Sciences Announces Acquisition of European-Focused Regulatory Partner: RApport Global Strategic Services
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm for the life sciences industry, today announced the acquisition of RApport Global Strategic Services (RApport). RApport is a UK based international regulatory consultancy supporting life science innovators gaining and maintaining authorization for products worldwide. ELIQUENT’s acquisition of RApport represents an important step in the company’s international growth and expanded European capabilities.
By ELIQUENT Life Sciences · Via Business Wire · January 18, 2024
ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer
ELIQUENT Life Sciences, a global regulatory consulting firm for the life sciences industry, today announced the appointment of Steve Purtell as its new chief financial officer (CFO). This strategic addition to ELIQUENT’s executive team underscores the company’s commitment to financial excellence and sustainable growth.
By ELIQUENT Life Sciences · Via Business Wire · January 11, 2024
Validant Group of Companies Unite as ELIQUENT Life Sciences
The Validant Group of companies today announced a strategic repositioning that unites the five companies as one global regulatory brand: ELIQUENT Life Sciences.
By ELIQUENT Life Sciences · Via Business Wire · January 8, 2024